Search Results 231-240 of 560 for ⚕보증사이트 【위너보증.com / 가입코드 9122】 정품슬롯 ⚕

  1. Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma - Mayo Clinic

    About this study. The purpose of this study is to estimate the event-free survival (EFS) distribution for newly-diagnosed patients with BRAFV600-mutant ...

  2. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    The primary purpose of this study is to assess the feasibility of performing lung and kidney and lung ultrasound elastography among patients with critical ...

  3. Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    The primary purpose of this study is to assess the feasibility of performing lung and kidney and lung ultrasound elastography among patients with critical ...

  5. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    The primary purpose of this study is to assess the feasibility of performing lung and kidney and lung ultrasound elastography among patients with critical ...

  6. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

  7. https://www.mayoclinic.org/spanish_condition_consolidated_concepts.xml

  8. https://www.mayoclinic.org/chinese_condition_consolidated_concepts.xml

  9. Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer - Mayo Clinic

    Androgens can cause the growth of prostate cancer cells. Drugs, such as enzalutamide, abiraterone acetate, and prednisone, may lessen the amount of androgens ...

  10. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.